BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 16731963)

  • 1. Structure of the 21-30 fragment of amyloid beta-protein.
    Baumketner A; Bernstein SL; Wyttenbach T; Lazo ND; Teplow DB; Bowers MT; Shea JE
    Protein Sci; 2006 Jun; 15(6):1239-47. PubMed ID: 16731963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aβ monomers transiently sample oligomer and fibril-like configurations: ensemble characterization using a combined MD/NMR approach.
    Rosenman DJ; Connors CR; Chen W; Wang C; García AE
    J Mol Biol; 2013 Sep; 425(18):3338-59. PubMed ID: 23811057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of preformed Asp23-Lys28 salt bridge on the conformational fluctuations of monomers and dimers of Abeta peptides with implications for rates of fibril formation.
    Reddy G; Straub JE; Thirumalai D
    J Phys Chem B; 2009 Jan; 113(4):1162-72. PubMed ID: 19125574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structures and free-energy landscapes of the wild type and mutants of the Abeta(21-30) peptide are determined by an interplay between intrapeptide electrostatic and hydrophobic interactions.
    Tarus B; Straub JE; Thirumalai D
    J Mol Biol; 2008 Jun; 379(4):815-29. PubMed ID: 18479708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structure of the Alzheimer amyloid beta 10-35 peptide probed through replica-exchange molecular dynamics simulations in explicit solvent.
    Baumketner A; Shea JE
    J Mol Biol; 2007 Feb; 366(1):275-85. PubMed ID: 17166516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of solvent on the structure of the Alzheimer amyloid-beta(25-35) peptide.
    Wei G; Shea JE
    Biophys J; 2006 Sep; 91(5):1638-47. PubMed ID: 16766615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibitory mechanism of a fullerene derivative against amyloid-β peptide aggregation: an atomistic simulation study.
    Sun Y; Qian Z; Wei G
    Phys Chem Chem Phys; 2016 May; 18(18):12582-91. PubMed ID: 27091578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid peptide Aβ40 inhibits aggregation of Aβ42: evidence from molecular dynamics simulations.
    Viet MH; Li MS
    J Chem Phys; 2012 Jun; 136(24):245105. PubMed ID: 22755606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of a water-soluble fullerene derivative with amyloid-β protofibrils: dynamics, binding mechanism, and the resulting salt-bridge disruption.
    Zhou X; Xi W; Luo Y; Cao S; Wei G
    J Phys Chem B; 2014 Jun; 118(24):6733-41. PubMed ID: 24857343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR.
    Petkova AT; Ishii Y; Balbach JJ; Antzutkin ON; Leapman RD; Delaglio F; Tycko R
    Proc Natl Acad Sci U S A; 2002 Dec; 99(26):16742-7. PubMed ID: 12481027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual effects of familial Alzheimer's disease mutations (D7H, D7N, and H6R) on amyloid β peptide: correlation dynamics and zinc binding.
    Xu L; Chen Y; Wang X
    Proteins; 2014 Dec; 82(12):3286-97. PubMed ID: 25137638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carnosine inhibits Aβ(42) aggregation by perturbing the H-bond network in and around the central hydrophobic cluster.
    Attanasio F; Convertino M; Magno A; Caflisch A; Corazza A; Haridas H; Esposito G; Cataldo S; Pignataro B; Milardi D; Rizzarelli E
    Chembiochem; 2013 Mar; 14(5):583-92. PubMed ID: 23440928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of familial Alzheimer's disease mutations on the folding nucleation of the amyloid beta-protein.
    Krone MG; Baumketner A; Bernstein SL; Wyttenbach T; Lazo ND; Teplow DB; Bowers MT; Shea JE
    J Mol Biol; 2008 Aug; 381(1):221-8. PubMed ID: 18597778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abeta40-Lactam(D23/K28) models a conformation highly favorable for nucleation of amyloid.
    Sciarretta KL; Gordon DJ; Petkova AT; Tycko R; Meredith SC
    Biochemistry; 2005 Apr; 44(16):6003-14. PubMed ID: 15835889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replica exchange molecular dynamics study of the truncated amyloid beta (11-40) trimer in solution.
    Ngo ST; Hung HM; Truong DT; Nguyen MT
    Phys Chem Chem Phys; 2017 Jan; 19(3):1909-1919. PubMed ID: 28004051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the familial Dutch mutation E22Q in the folding and aggregation of the 15-28 fragment of the Alzheimer amyloid-beta protein.
    Baumketner A; Krone MG; Shea JE
    Proc Natl Acad Sci U S A; 2008 Apr; 105(16):6027-32. PubMed ID: 18408165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural properties of amyloid β(1-40) dimer explored by replica exchange molecular dynamics simulations.
    Watts CR; Gregory AJ; Frisbie CP; Lovas S
    Proteins; 2017 Jun; 85(6):1024-1045. PubMed ID: 28241387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of force fields on the conformational and dynamic properties of amyloid β(1-40) dimer explored by replica exchange molecular dynamics simulations.
    Watts CR; Gregory A; Frisbie C; Lovas S
    Proteins; 2018 Mar; 86(3):279-300. PubMed ID: 29235155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and dynamics of parallel beta-sheets, hydrophobic core, and loops in Alzheimer's A beta fibrils.
    Buchete NV; Hummer G
    Biophys J; 2007 May; 92(9):3032-9. PubMed ID: 17293399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-specific identification of non-beta-strand conformations in Alzheimer's beta-amyloid fibrils by solid-state NMR.
    Antzutkin ON; Balbach JJ; Tycko R
    Biophys J; 2003 May; 84(5):3326-35. PubMed ID: 12719262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.